These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7752193)

  • 1. Dicarboxylic acid dipeptide neutral endopeptidase inhibitors.
    Ksander GM; Ghai RD; deJesus R; Diefenbacher CG; Yuan A; Berry C; Sakane Y; Trapani A
    J Med Chem; 1995 May; 38(10):1689-700. PubMed ID: 7752193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic profile of CGS 24128, a potent, long-acting inhibitor of neutral endopeptidase 24.11.
    Trapani AJ; Beil ME; Coté DT; de Lombaert S; Erion MD; Gerlock TE; Ghai RD; Hopkins MF; Peppard JV; Webb RL
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):358-64. PubMed ID: 7515977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of SQ 28,603, an inhibitor of neutral endopeptidase, in conscious monkeys.
    Seymour AA; Abboa-Offei B; Asaad MM; Rogers WL
    Can J Physiol Pharmacol; 1991 Oct; 69(10):1609-17. PubMed ID: 1663819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11.
    Chatelain RE; Ghai RD; Trapani AJ; Odorico LM; Dardik BN; De Lombaert S; Lappe RW; Fink CA
    J Pharmacol Exp Ther; 1998 Mar; 284(3):974-82. PubMed ID: 9495857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New alpha-thiol dipeptide dual inhibitors of angiotensin-I converting enzyme and neutral endopeptidase EC 3.4.24.11.
    Fink CA; Qiao Y; Berry CJ; Sakane Y; Ghai RD; Trapani AJ
    J Med Chem; 1995 Dec; 38(26):5023-30. PubMed ID: 8544178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme: rational design, bioavailability, and pharmacological responses in experimental hypertension.
    Fournié-Zaluski MC; Coric P; Turcaud S; Rousselet N; Gonzalez W; Barbe B; Pham I; Jullian N; Michel JB; Roques BP
    J Med Chem; 1994 Apr; 37(8):1070-83. PubMed ID: 8164250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of kinins and atrial natriuretic peptide on the renal effects of neutral endopeptidase inhibitor in rats.
    Ura N; Shimamoto K; Kuroda S; Nomura N; Iwata M; Aoyama T; Iimura O
    Clin Exp Hypertens; 1994 Nov; 16(6):799-808. PubMed ID: 7858560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute hemodynamic, hormonal, and renal effects of neutral endopeptidase inhibition in ovine heart failure.
    Fitzpatrick MA; Rademaker MT; Charles CJ; Yandle TG; Espiner EA; Ikram H; Sybertz E
    J Cardiovasc Pharmacol; 1992 Apr; 19(4):635-40. PubMed ID: 1380608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure.
    Cavero PG; Margulies KB; Winaver J; Seymour AA; Delaney NG; Burnett JC
    Circulation; 1990 Jul; 82(1):196-201. PubMed ID: 2142023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of neutral endopeptidase inhibition in euvolemic and hypervolemic rats.
    Scott JM; Barclay PL; Shepperson NB
    Eur J Pharmacol; 1993 Sep; 242(1):91-7. PubMed ID: 8223941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutral endopeptidase inhibition potentiates the natriuretic actions of adrenomedullin.
    Lisy O; Jougasaki M; Schirger JA; Chen HH; Barclay PT; Burnett JC
    Am J Physiol; 1998 Sep; 275(3):F410-4. PubMed ID: 9729514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
    Fink CA; Carlson JE; McTaggart PA; Qiao Y; Webb R; Chatelain R; Jeng AY; Trapani AJ
    J Med Chem; 1996 Aug; 39(16):3158-68. PubMed ID: 8759637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats.
    Seymour AA; Asaad MM; Abboa-Offei BE; Rovnyak PL; Fennell S; Rogers WL
    J Pharmacol Exp Ther; 1992 Jul; 262(1):60-70. PubMed ID: 1385630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natriuretic mechanisms of neutral endopeptidase inhibitor in rats.
    Shimamoto K; Ura N; Iimura O
    Braz J Med Biol Res; 1994 Aug; 27(8):1965-73. PubMed ID: 7749388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based design of dipeptide derivatives for the human neutral endopeptidase.
    Misawa K; Suzuki Y; Takahashi S; Yoshimori A; Takasawa R; Shibuya Y; Tanuma S
    Bioorg Med Chem; 2011 Oct; 19(20):5935-47. PubMed ID: 21937235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the ECE/NEP inhibitor CGS 34225 on the big ET-1-induced pressor response and plasma atrial natriuretic peptide concentration in conscious rats.
    Trapani AJ; Beil ME; Bruseo CW; Fink CA; Hoyer D; Savage P; Jeng AY
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():102S-106S. PubMed ID: 12193065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
    Gonzalez Vera W; Fournié-Zaluski MC; Pham I; Laboulandine I; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1995 Jan; 272(1):343-51. PubMed ID: 7815350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
    Robl JA; Sun CQ; Stevenson J; Ryono DE; Simpkins LM; Cimarusti MP; Dejneka T; Slusarchyk WA; Chao S; Stratton L; Misra RN; Bednarz MS; Asaad MM; Cheung HS; Abboa-Offei BE; Smith PL; Mathers PD; Fox M; Schaeffer TR; Seymour AA; Trippodo NC
    J Med Chem; 1997 May; 40(11):1570-7. PubMed ID: 9171867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of neutral endopeptidase in dogs with evolving congestive heart failure.
    Margulies KB; Barclay PL; Burnett JC
    Circulation; 1995 Apr; 91(7):2036-42. PubMed ID: 7895362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of neutral endopeptidase 3.4.24.11 in conscious dogs with pacing induced heart failure.
    Seymour AA; Asaad MM; Lanoce VM; Fennell SA; Cheung HS; Rogers WL
    Cardiovasc Res; 1993 Jun; 27(6):1015-23. PubMed ID: 8221758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.